Private Equity's Inversion Excursion: Pepper Hamilton Talks Tax With the Deal
For years, the Justice Department and the Securities and Exchange Commission touted the FCPA “sweep” of the pharmaceutical and medical device industries. With good reason, DOJ and the SEC turned the drug and medical device...more